Enhanced prevalence of plasmatic soluble MHC class I chain-related molecule in vascular pregnancy diseases - Wikidata - awgldk - TriplyDB

Enhanced prevalence of plasmatic soluble MHC class I chain-related molecule in vascular pregnancy diseases

Enhanced prevalence of plasmatic soluble MHC class I chain-related molecule in vascular pregnancy diseases

http://www.wikidata.org/entity/Q33417775

about

Longitudinal assessment of HLA and MIC-A antibodies in uneventful pregnancies and pregnancies complicated by preeclampsia or gestational diabetes.Elucidating the Pathogenesis of Pre-eclampsia Using In Vitro Models of Spiral Uterine Artery Remodelling.

P2860

Q42670153-090DBB25-A67F-442E-A0B7-17210F2EFDC3 Q45398781-56D731C1-2DE8-4FC7-A926-00278CC19563

P2860

Enhanced prevalence of plasmatic soluble MHC class I chain-related molecule in vascular pregnancy diseases

http://www.wikidata.org/entity/Q33417775

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Enhanced prevalence of plasmat ...... in vascular pregnancy diseases

@ast

Enhanced prevalence of plasmat ...... in vascular pregnancy diseases

@en

type

label

Enhanced prevalence of plasmat ...... in vascular pregnancy diseases

@ast

Enhanced prevalence of plasmat ...... in vascular pregnancy diseases

@en

prefLabel

Enhanced prevalence of plasmat ...... in vascular pregnancy diseases

@ast

Enhanced prevalence of plasmat ...... in vascular pregnancy diseases

@en

P1433

Q33417775-8C467DA7-0259-4DAC-9A79-62AC287BA281

P1476

Q33417775-F46FB558-75D9-434D-B829-46B44C7A09E5

P2093

Q33417775-01269693-6A97-43BD-ADDC-4444F1467939

Q33417775-14738033-6146-466C-82A4-FB105F1F691C

Q33417775-19566E08-1F61-4EAD-B476-AC26EF8A6DD7

Q33417775-195B8B40-86EF-42A0-85E9-D5668ABD2995

Q33417775-1C81230D-53F2-4084-86FB-9C7F42983D97

Q33417775-62A60A27-E3C5-4A23-9242-5A2988FF061D

Q33417775-8684FB3E-26DF-4861-8518-833C4CF6B127

Q33417775-A7120438-FFCA-45BD-9F1B-D21EDE9FB43F

P2860

Q33417775-0286163B-FFFD-4369-8542-9B35E384604A

Q33417775-0410176E-2403-47E9-A3BF-987D047CDB57

Q33417775-0B807CB0-9711-46B4-88AF-CF8D261900A0

Q33417775-128D81D7-1563-4399-A74C-BC25CE1FFC0F

Q33417775-12BBBC40-8D51-44C0-95C6-E1D8FE135F1F

Q33417775-2267B3D1-474B-497E-9279-163483B7CD6B

Q33417775-2BF7516F-2B49-42BA-94A0-30EC6738E7D7

Q33417775-2DEE8D62-4D99-4D5F-96D6-441226094F73

Q33417775-2EA832E3-A74A-4E36-A121-C0B59A5B133C

Q33417775-338AD658-D124-4F90-88A4-BC59B05B2D0C

P304

Q33417775-2D380576-7E68-425E-892C-2A37B460EDF3

P31

Q33417775-11E2F815-9D87-4646-B3FA-F196E22CA26F

P356

Q33417775-7129DDF4-8688-4FE3-BE9E-67CAEA7099FD

P407

Q33417775-64BE6291-DFB6-44D2-9E06-04008100009B

P478

Q33417775-25F3AEBB-771E-4677-A1D0-ECBF9C82156E

P50

Q33417775-33434ADD-D783-4E32-8CB7-F5FCEB886B7B

Q33417775-9826137F-61D9-4DA1-8C32-C37F7749F77D

Q33417775-A33F0786-60BF-4780-AF2F-4D8A91EE013C

Q33417775-C55A2841-1BDE-4E3D-A726-830C7C6414FE

P577

Q33417775-1C98EB00-08FB-4F08-A2C3-CA5B96490DE5

P5875

Q33417775-E80215BF-13C4-4CFB-82CC-A625A43A646B

P698

Q33417775-E91FD80D-5227-4109-B15D-01FC096B7944

P932

Q33417775-F737F5B5-4D62-4FE1-A0E0-26EF03011564

P356

P1433

BioMed Research International

P1476

Enhanced prevalence of plasmat ...... in vascular pregnancy diseases

@en

P2093

Agostini Aubert

http://www.w3.org/2001/XMLSchema#string

Annie Levy-Mozziconacci

http://www.w3.org/2001/XMLSchema#string

Catherine Farnarier

http://www.w3.org/2001/XMLSchema#string

Jean Baptiste Haumonte

http://www.w3.org/2001/XMLSchema#string

Laurence Camoin-Jau

http://www.w3.org/2001/XMLSchema#string

Leon Boubli

http://www.w3.org/2001/XMLSchema#string

Luc Lyonnet

http://www.w3.org/2001/XMLSchema#string

Marion Lambert

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of NK cells by an endocytosed receptor for soluble HLA-G.

Controlling the Immunological Crosstalk during Conception and Pregnancy: HLA-G in Reproduction

Angiogenic factors in diagnosis, management, and research in preeclampsia.

UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells

Soluble endoglin contributes to the pathogenesis of preeclampsia

A novel pro-angiogenic function for interferon-γ-secreting natural killer cells

HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy.

Characterization of uterine NK cells in women with infertility or recurrent pregnancy loss and associated endometriosis

[Pathophysiology of preeclampsia: some recent data].

Pregnancy immunogenetics: NK cell education in the womb?

P304

653161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/653161

http://www.w3.org/2001/XMLSchema#string

P407

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

Florence Bretelle

Sophie Caillat-Zucman

Françoise Dignat-George

P577

2014-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266028919

http://www.w3.org/2001/XMLSchema#string

P698

25243172

http://www.w3.org/2001/XMLSchema#string

P932

4160641

http://www.w3.org/2001/XMLSchema#string